WO2015070394A1 - Method for preparing penem antibiotic intermediate - Google Patents
Method for preparing penem antibiotic intermediate Download PDFInfo
- Publication number
- WO2015070394A1 WO2015070394A1 PCT/CN2013/087038 CN2013087038W WO2015070394A1 WO 2015070394 A1 WO2015070394 A1 WO 2015070394A1 CN 2013087038 W CN2013087038 W CN 2013087038W WO 2015070394 A1 WO2015070394 A1 WO 2015070394A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reaction
- chemical formula
- compound represented
- compound
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 9
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 title claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 95
- 238000006243 chemical reaction Methods 0.000 claims abstract description 69
- 238000006683 Mannich reaction Methods 0.000 claims abstract description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 51
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 17
- 239000002841 Lewis acid Substances 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 9
- 150000007517 lewis acids Chemical class 0.000 claims description 9
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 8
- 239000002879 Lewis base Substances 0.000 claims description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 7
- 150000007527 lewis bases Chemical class 0.000 claims description 7
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 6
- 239000000543 intermediate Substances 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 6
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 claims description 4
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims description 4
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 claims description 3
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 claims description 3
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 2
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 229940043279 diisopropylamine Drugs 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- ICAKDTKJOYSXGC-UHFFFAOYSA-K lanthanum(iii) chloride Chemical compound Cl[La](Cl)Cl ICAKDTKJOYSXGC-UHFFFAOYSA-K 0.000 claims description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005049 silicon tetrachloride Substances 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- UBZYKBZMAMTNKW-UHFFFAOYSA-J titanium tetrabromide Chemical compound Br[Ti](Br)(Br)Br UBZYKBZMAMTNKW-UHFFFAOYSA-J 0.000 claims description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 2
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 claims description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 2
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical compound CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 claims 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 1
- 229940092714 benzenesulfonic acid Drugs 0.000 claims 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 claims 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 claims 1
- 229940102001 zinc bromide Drugs 0.000 claims 1
- 238000003912 environmental pollution Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 20
- 238000003756 stirring Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- -1 pro-radical Chemical class 0.000 description 9
- 235000019439 ethyl acetate Nutrition 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000007791 liquid phase Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 0 C[C@@](*)[C@]([C@](N1)OC(C)=O)(C1=O)S Chemical compound C[C@@](*)[C@]([C@](N1)OC(C)=O)(C1=O)S 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- XJMIXEAZMCTAGH-UHFFFAOYSA-N methyl 3-oxopentanoate Chemical compound CCC(=O)CC(=O)OC XJMIXEAZMCTAGH-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- NNANGMFTFSNDLW-GWOFURMSSA-N (2r)-2-[(2s,3s)-3-[(1r)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]propanoic acid Chemical compound CC(C)(C)[Si](C)(C)O[C@H](C)[C@@H]1[C@@H]([C@@H](C)C(O)=O)NC1=O NNANGMFTFSNDLW-GWOFURMSSA-N 0.000 description 3
- ZCRVPHKAQIHANY-UHFFFAOYSA-N (ne)-n-diazo-2-dodecylbenzenesulfonamide Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(=O)(=O)N=[N+]=[N-] ZCRVPHKAQIHANY-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical compound C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- BWRBVBFLFQKBPT-UHFFFAOYSA-N (2-nitrophenyl)methanol Chemical compound OCC1=CC=CC=C1[N+]([O-])=O BWRBVBFLFQKBPT-UHFFFAOYSA-N 0.000 description 1
- PTHGDVCPCZKZKR-UHFFFAOYSA-N (4-chlorophenyl)methanol Chemical compound OCC1=CC=C(Cl)C=C1 PTHGDVCPCZKZKR-UHFFFAOYSA-N 0.000 description 1
- KJMCAXYHYPDRAV-UHFFFAOYSA-N 2,2,5-trimethyl-1,3-dioxane-4,6-dione Chemical compound CC1C(=O)OC(C)(C)OC1=O KJMCAXYHYPDRAV-UHFFFAOYSA-N 0.000 description 1
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 description 1
- DPGBHCGFIJENSU-UHFFFAOYSA-N 4-acetylazetidin-2-one Chemical compound CC(=O)C1CC(=O)N1 DPGBHCGFIJENSU-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- MDOPFYCLQFOWRF-UHFFFAOYSA-N C(C)C(CN(CC)CC)(CC)CC Chemical compound C(C)C(CN(CC)CC)(CC)CC MDOPFYCLQFOWRF-UHFFFAOYSA-N 0.000 description 1
- SMXAZWYBTRQZMQ-UHFFFAOYSA-N CCC(C(C(OC)=O)=N)=O Chemical compound CCC(C(C(OC)=O)=N)=O SMXAZWYBTRQZMQ-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- JUZNIMUFDBIJCM-ANEDZVCMSA-N Invanz Chemical compound O=C([C@H]1NC[C@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)NC1=CC=CC(C(O)=O)=C1 JUZNIMUFDBIJCM-ANEDZVCMSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 238000006680 Reformatsky reaction Methods 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229910003902 SiCl 4 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUGVQALCOCWLET-UHFFFAOYSA-F [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ti+4].[Ti+4] Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ti+4].[Ti+4] XUGVQALCOCWLET-UHFFFAOYSA-F 0.000 description 1
- FGHAZDVJHATENE-UHFFFAOYSA-N [N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[NH6+3] Chemical compound [N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[NH6+3] FGHAZDVJHATENE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- DALDUXIBIKGWTK-UHFFFAOYSA-N benzene;toluene Chemical compound C1=CC=CC=C1.CC1=CC=CC=C1 DALDUXIBIKGWTK-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 description 1
- PRVGNTVFNDHYSU-UHFFFAOYSA-N dimethylsilylhydrazine Chemical compound C[SiH](NN)C PRVGNTVFNDHYSU-UHFFFAOYSA-N 0.000 description 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 description 1
- 229960000895 doripenem Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960002770 ertapenem Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 1
- 229960002260 meropenem Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Definitions
- the invention relates to the field of synthesis of pharmaceutical intermediates, in particular to a preparation method of a Pein-like antibiotic intermediate. Background technique
- Pein-type drugs such as meropenem, doripenem and ertapenem are a class of broad-spectrum antibiotics for ⁇ -lactam injection. It is well known that the compound represented by the formula (la) is a card catalyzed by ruthenium.
- the synthetic route shown in Reaction Scheme 2 is currently widely used.
- the compound of the formula (la) can be subjected to CDI activation, nucleophilic addition reaction and decarboxylation reaction, and removal of TBS (t-butyl group) by ⁇ -methyl-ADC-8 (4-oxime, compound of formula (V)).
- Dimethylsilyl hydrazine and the diazotization reaction involving t-decylbenzenesulfonyl azide are conveniently prepared. 0. Am. Chem. Soc, 1980, 102 6161-6163).
- a difficulty with this route is the preparation of a compound represented by the chiral ⁇ -methyl formula (V).
- 4-Acetylazetidinone (4AA, a compound of formula (VIII)) is generally used to prepare 4-BMA (reviewed in detail: Tetrahedron, 1996, 52, 33 1 -375).
- 4-BMA (US53 10897, US4873324, EP230792, reaction formula 3) can be produced in a high yield and high selectivity by an asymmetric hydrogenation reaction.
- the preparation of the compound of the formula (IX) is difficult.
- the compound of the formula (XIV) can be obtained by a series of reactions of 4AA by a coupling reaction of isopropylidene methylmalonate, N-silylation and solvolysis of methyl isopropylidene malonate.
- the acid-catalyzed asymmetric hydrolysis and removal of the protecting group can then give 4-indole at a ⁇ -selectivity of >10:1.
- a primary object of the present invention is to provide a simple and commercially valuable synthetic route for the preparation of a compound of the formula by a two-step reaction of a compound of formula (II).
- Another object of the present invention is to provide a high ⁇ -selective method for direct Mannich addition of a compound of the formula (II) using a compound of the formula ⁇ ).
- the present invention also provides optimum reaction conditions for the Mannich reaction.
- the present invention provides a process for preparing a penicillin antibiotic intermediate represented by the chemical formula ⁇ ), which comprises the steps shown in Reaction Scheme 7.
- the compound represented by the chemical formula ⁇ ) is abbreviated as the compound ⁇ ), and the other compounds are also referred to as corresponding abbreviations.
- TBS tert-butyldimethylsilyl
- the functional group represented by R 1 includes, but is not limited to, methyl (Me), ethyl (Et), p-nitrobenzyl (PNB), benzyl (Bn), allyl (Allyl), 4-chlorobenzyl, 2-nitrobenzyl, 3-nitrobenzyl, 4-methoxybenzyl;
- R 2 includes, but is not limited to, acetyl (Ac), benzoyl (Bz);
- R 2 The functional groups represented by R 2 include, but are not limited to, trimethylsilyl (TMS), tert-butyldimethylsilyl (TBS).
- TMS trimethylsilyl
- TBS tert-butyldimethylsilyl
- the compound of the formula (III) can be easily synthesized by a conventional method.
- Equation 7 The content in Equation 7 consists essentially of two steps:
- Step h The compound of the formula ( ⁇ ) is reacted with a compound of the formula ⁇ ) to obtain a compound of the formula (XVI);
- Step 2 The compound represented by the chemical formula (XVI) is prepared, that is, ⁇ - Methylpenic antibiotic intermediate.
- Steps 1 and 2 are carried out according to the following reaction conditions:
- step 1 the reaction can be carried out under a variety of known Lewis acid catalyzed direct Mannich reactions. After the reaction is completed, various methods can be used for post treatment.
- the Lewis acid used in the Mannich reaction may be any of the existing acids used in the Mannich reaction, including but not limited to titanium tetrachloride (TiCl 4 ), titanium tetrabromide (TiBr 4 ), silicon tetrachloride (SiCl 4 ).
- lanthanum trichloride LaCl 3
- zinc chloride ZnCl 2
- zinc bromide ZnBr 2
- magnesium chloride MgCl 2
- boron tribromide BBr 3
- copper chloride CuCl 2
- Copper triflate Cu(OTf) 2
- cuprous triflate CuOTf
- cuprous iodide Cul
- boron trichloride BC1 3
- the molar ratio of the Lewis acid to the compound of the formula (II) is 0.8 to 3.0:1, preferably 1.0 to 1.5: l o If less Lewis acid is used, the reaction cannot be completed.
- a Lewis base is also present in the reaction of step 1.
- the Lewis base may be any of the bases currently used in the Mannich reaction, including but not limited to triethylamine, diisopropylethylamine, tri-n-butylamine, tetramethylethylenediamine, 4-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diazabicyclo[2.2.2]octane, 4-dimethylaminopyridine, N-methyl Pyrrolizine, N-methylpiperidine, diethylamine, diisopropylamine, pyrrole, piperidine, hexamethylphosphoric triamide, pyridine, 3-methylpyridine, and combinations thereof. It is preferred to use a tertiary amine therein.
- the molar ratio of the Lewis base to the compound of the formula (II) is from 1.2 to 4.0:1, preferably
- the reaction of the step 1 is usually carried out by dissolving the compound of the formula in an organic solvent, cooling, then adding a Lewis acid and a Lewis base, stirring, adding a compound of the formula ( ⁇ ), and then reacting until the end.
- the solvent includes methylene chloride, 1,2-dichloroacetonitrile, toluene, acetonitrile, tetrahydrofuran, methyl t-butyl ether, 2-methyltetrahydrofuran or a combination thereof.
- methylene chloride, 1,2-dichloroethane or a combination thereof is used.
- the solvent is used in an amount of 8 to 30 mL/g based on the compound of the formula ( ⁇ ) (i.e., 8 to 30 mL of the solvent per gram of the compound represented by the formula ( ⁇ ), preferably 12 to 20 mL/g.
- the molar ratio of the compound of the formula (III) to the compound of the formula ( ⁇ ) is 1.0 to 2.0: 1, preferably 1.2 to 1.5: 1.
- the reaction temperature in the step 1 is -60 to 10 ° C, preferably -30 to 0 ° C.
- a suitable temperature for the addition of the Lewis acid and the Lewis base is -60 to 0 ° C, preferably -50 to 30 ° C.
- the appropriate stirring time before the addition of the compound of the formula (II) should be 10 to 60 minutes, preferably 20 to 30 minutes.
- a suitable temperature for the addition of the compound of the formula (II) is -60 to 0 ° C, preferably -40 to 20 ° C.
- a suitable temperature for the reaction is -40 to 10 ° C, preferably -20 to 0 ° C.
- the reaction will proceed very slowly at lower temperatures.
- the appropriate reaction time should be within 4 hours and, if possible, the reaction should be completed within 2.5 hours. Longer reaction times result in more impurities and lower yields.
- the reaction is quenched with an aqueous solution such as aqueous sodium chloride solution, aqueous sodium hydrogencarbonate solution, aqueous sodium dihydrogen phosphate solution, aqueous potassium dihydrogen phosphate solution, aqueous magnesium chloride solution, aqueous calcium chloride solution or purified water, preferably using pure water.
- an aqueous solution such as aqueous sodium chloride solution, aqueous sodium hydrogencarbonate solution, aqueous sodium dihydrogen phosphate solution, aqueous potassium dihydrogen phosphate solution, aqueous magnesium chloride solution, aqueous calcium chloride solution or purified water, preferably using pure water.
- concentration of the aqueous solution is a concentration of a common quenching solution, and preferably the mass percentage of the solute may be 5% to 25%.
- the amount of the quenching solution is 3 to 30 mL/g, preferably 5 to 10 mL/g, based on the compound of the formula ( ⁇ ).
- the compound of the formula (XVI) obtained in the step 1 can be directly used for the next reaction, or can be further purified, preferably using methanol, methanol-water, ethanol, ethanol-water, acetone, acetone-water, acetonitrile.
- Solvents such as isopropanol, n-hexanol, n-glycol, toluene, petroleum ether, etc. are purified by recrystallization, more preferably by recrystallization from methanol-water.
- the amount of the recrystallization solvent is from 3 to 20 mL/g, preferably from 4 to 8 mL/g, based on the compound of the formula (II). Using more solvent will reduce the yield.
- the reaction can be carried out under various reaction conditions in which the acid is removed by the removal of the t-butyldimethylsilyl group or the trimethylsilyl group. After the completion of the reaction, various methods can be used for the post treatment.
- the acid used for removing tert-butyldimethylsilyl or trimethylsilyl protection includes hydrochloric acid (HC1), sulfuric acid (H 2 S0 4 ), methanesulfonic acid (MeS0 3 H), benzenesulfonate. Acid (PhS0 3 H) and trifluoroacetic acid, preferably hydrochloric acid.
- the concentration of the hydrochloric acid for protecting the tert-butyldimethylsilyl or trimethylsilyl group is 0.5-4 mol/L, preferably 1.0 to 2.0 mol/L.
- the reaction of the step 2 is carried out in a solvent selected from the group consisting of a mixed solvent of acetonitrile-water, methanol-water, acetone-water, tetrahydrofuran-water, etc., wherein the volume concentration of the organic solvent ranges from 40% to ⁇ 80%, preferably an acetonitrile-water solution having a volume concentration of 40% to 80% acetonitrile is used as a reaction solvent.
- the amount of the solvent used is 4 to 15 mL/g, preferably 6 to 10 mL/g, based on the compound of the formula (XVI).
- the suitable temperature for the step 2 reaction is 0 to 30 ° C, preferably 15 to 20 ° C.
- the preparation method provided by the present invention has obvious advantages.
- the reaction step is greatly shortened, and it is required to prepare a compound represented by the chemical formula ⁇ ) from the compound represented by the chemical formula ⁇ )
- the preparation method used in the present invention requires only 2 steps, so the reaction cycle is greatly shortened, labor costs are saved, equipment investment for commercial production is reduced, and the types and amounts of solvents used are reduced. The pollution is also relatively reduced, while saving the production costs of the factory.
- the preparation method of the present invention is easily obtained as a raw material, and the selectivity and yield of the obtained product are remarkably improved as compared with the prior art. detailed description
- the compound of formula (Ilia) (188 g) was dissolved in dichloromethane (1500 mL), cooled to -40 ° C, and titanium tetrachloride (104 g) in dichloromethane (300 mL) was slowly added. The resulting yellow slurry was stirred for a further 30 minutes. Triethylamine (105 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (150 g) in dichloromethane (300 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to 5 ° C then quenched with water (750 mL).
- the compound of formula (XVIa) (51 g) is suspended in acetonitrile with 40% by volume of acetonitrile.
- Step reaction should be. .
- the crude crude product of the chemical compound represented by the above-mentioned chemical formula ((XXVVIIIIbb)) is added at about 2200 ° ° CC, toluene benzene ((330000 mm LL) And triethyltriethylamine ((3355..44 gg)), and then post-drip plus p-dodecyldiphenylbenzenesulfonyl-lacide azide nitrogen (227700 ..44 gg)). . After the drop is completed, 5 will return to the room temperature and the reaction should be 55 hours. .
- the reaction system is concentrated and concentrated to about 220000 ⁇ 330000 mmLL, and then added to the positive gengbeng ((550000 mmLL)), and the ice-cold water bath is cooled by cooling and stirred. Mix about 55 hours. .
- the filter cake is washed and washed with Zheng Geng Geng, dried and dried to obtain the chemical compound represented by the chemical formula ((nniibb)) ((112266) Gg,, yield yield: 6677%%)), liquid-liquid phase purity purity 9999..44%%. .
- Methyl 3-oxopentanoate (30 g), toluene (150 mL) and triethylamine (11.6 g) were added at about 15 ° C, then p-dodecylbenzenesulfonyl azide (89.1 g) was added dropwise. After the dropwise addition, the mixture was naturally returned to room temperature for 5 hours. The reaction system was concentrated to a fraction. The crude product was purified by silica gel column chromatography to give the compound of formula (IIIc) (33.8 g, yield 94%), and the liquid phase purity was 98.5%.
- Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes.
- Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 ° C for 3 hours, The reaction was warmed to rt then EtOAc (EtOAc)EtOAc. The mixture was allowed to stand for separation, the methylene chloride phase was separated, and then concentrated to give a crude product of the formula (XVId).
- Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes.
- Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to EtOAc EtOAc. The mixture was allowed to stand for separation, and the methylene chloride phase was separated, and then concentrated to give 47.4 g of crude compound of formula (XVI).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a method for preparing a penem antibiotic intermediate. The method comprises the following steps: step 1: preparing an intermediate compound by means of a Mannich reaction; and step 2: converting the intermediate compound into a penem antibiotic intermediate. The method shortens the reaction period, reduces the cost, and reduces environmental pollution, and reaction materials are easily obtained; and the selectivity and the yield of the method are remarkably improved in comparison with the prior art.
Description
一种制备培南类抗生素中间体的方法 技术领域 Method for preparing perennial antibiotic intermediates
本发明涉及药物中间体合成领域,具体涉及一种培南类抗生素中间体 的制备方法。 背景技术 The invention relates to the field of synthesis of pharmaceutical intermediates, in particular to a preparation method of a Pein-like antibiotic intermediate. Background technique
培南类药物如美罗培南、 多尼培南和尔他培南是一类 β-内酰胺类注 射用广谱抗生素。 众所周知, 化学式 (la)所示的化合物是采用铑催化的卡 Pein-type drugs such as meropenem, doripenem and ertapenem are a class of broad-spectrum antibiotics for β-lactam injection. It is well known that the compound represented by the formula (la) is a card catalyzed by ruthenium.
反应式 2所示的合成路线是目前被广泛采用的。 化学式 (la)所示化合 物可以由 β-甲基 -ADC-8 (4-ΒΜΑ, 化学式 (V)所示化合物)经 CDI活化、 亲核加成反应和脱羧反应、脱除 TBS (叔丁基二甲基硅基 Μ呆护和对十二垸 基苯磺酰叠氮参与的重氮化反应方便的制备 0/. Am. Chem. Soc , 1980, 102 6161-6163)。 此路线的难点是带有手性 β-甲基化学式 (V)所示化合物的制 备。 The synthetic route shown in Reaction Scheme 2 is currently widely used. The compound of the formula (la) can be subjected to CDI activation, nucleophilic addition reaction and decarboxylation reaction, and removal of TBS (t-butyl group) by β-methyl-ADC-8 (4-oxime, compound of formula (V)). Dimethylsilyl hydrazine and the diazotization reaction involving t-decylbenzenesulfonyl azide are conveniently prepared. 0. Am. Chem. Soc, 1980, 102 6161-6163). A difficulty with this route is the preparation of a compound represented by the chiral β-methyl formula (V).
4-乙酰基氮杂环丁酮 (4AA, 化学式 (VIII)所示化合物)通常被用于制 备 4-BMA (相关综述: Tetrahedron, 1996, 52, 33 1 -375)。 例如, 由 4AA制 备得到带有末端双键的化学式 (IX)所示化合物,然后通过不对称氢化反应 可以高产率高选择性的制备 4-BMA (US53 10897、US4873324、 EP230792 , 反应式 3)。 然而化学式 (IX)所示化合物制备比较困难。 4-Acetylazetidinone (4AA, a compound of formula (VIII)) is generally used to prepare 4-BMA (reviewed in detail: Tetrahedron, 1996, 52, 33 1 -375). For example, a compound of the formula (IX) having a terminal double bond is prepared from 4AA, and then 4-BMA (US53 10897, US4873324, EP230792, reaction formula 3) can be produced in a high yield and high selectivity by an asymmetric hydrogenation reaction. However, the preparation of the compound of the formula (IX) is difficult.
反应式 3 另一条通过 4AA 制备 4-BMA 的途径是采用辅基诱导的不对称 Reformatsky 反应。 有多种辅基均报道有很好的 β-选择性 (US4791207、 US5104984、 EP197432 , JP06065195)。 然而合成和脱除辅基需要额外的 步骤, 导致成本上升。 Reaction Scheme 3 Another route for the preparation of 4-BMA by 4AA is the use of a pro-radical-induced asymmetric Reformatsky reaction. A variety of prosthetic groups have been reported to have good β-selectivity (US4791207, US5104984, EP197432, JP06065195). However, the synthesis and removal of the prosthetic group requires additional steps, resulting in increased costs.
XI XII XIII XI XII XIII
反应式 4 还有一种方法是由默克公司开发的
Lett. 1994, 35, 2275-2278)。化学式 (XIV)所示化合物可以由 4AA通过甲基丙二 酸亚异丙酯的偶联反应、 N-硅基化和甲基丙二酸亚异丙酯的溶剂解等一 系列反应得到。 然后经过酸催化的不对称水解和脱除保护基可以以>10: 1 的 β-选择性得到 4-ΒΜΑ。 Another method is developed by Merck. Lett. 1994, 35, 2275-2278). The compound of the formula (XIV) can be obtained by a series of reactions of 4AA by a coupling reaction of isopropylidene methylmalonate, N-silylation and solvolysis of methyl isopropylidene malonate. The acid-catalyzed asymmetric hydrolysis and removal of the protecting group can then give 4-indole at a β-selectivity of >10:1.
反应式 5 百时美施贵宝公司报道过一系列由 4AA通过直接 Mannich反应制备
化学式(I)所示化合物或其类似物的路线
Letters, 1987, 28, 507-510; Tetrahedron Letters, 1988, 29, 61 -64; Can. J. Chem. 1988, 6, 1400-1404)。 然而这些反应均得到很低的 β-选择性或者很低的产率。 Reaction Formula 5 Bristol-Myers Squibb reported a series of preparations prepared by direct Mannich reaction from 4AA. Route of a compound of formula (I) or an analogue thereof Letters, 1987, 28, 507-510; Tetrahedron Letters, 1988, 29, 61-64; Can. J. Chem. 1988, 6, 1400-1404). However, these reactions all result in very low β-selectivity or very low yield.
ZnCI2: 78:22 β选择性, 75%收率 ZnCI 2 : 78:22 β selectivity, 75% yield
4ΑΑ 4 5 4ΑΑ 4 5
SnCI2: 69:31 β选择性, 70%收率 SnCI 2 : 69:31 β selectivity, 70% yield
TMSOTf: 57:43 β选择性, 75% 收率 TMSOTf: 57:43 β selectivity, 75% yield
MgBr2: 83:17 β 选择性, 8%收率 反应式 6 在持续的开发制备化学式 (IVa)所示化合物及其类似化合物新路线的 过程中,本发明发明人找到一条不仅具有商业价值的,而且具有较短合成 步骤和简单化学的合成路线。本发明的技术内容未见于以往的报道和工作 中。 发明内容 MgBr 2 : 83:17 β selectivity, 8% yield reaction formula 6 In the course of continuous development of a new route for the preparation of the compound of the formula (IVa) and its analogous compounds, the inventors of the present invention found a commercial value. And a synthetic route with shorter synthesis steps and simple chemistry. The technical content of the present invention is not found in previous reports and work. Summary of the invention
本发明的主要目的是提供一条由化学式 (II)所示化合物通过两步反应 制备化学式 所示化合物的简单而且具有商业价值的合成路线。 SUMMARY OF THE INVENTION A primary object of the present invention is to provide a simple and commercially valuable synthetic route for the preparation of a compound of the formula by a two-step reaction of a compound of formula (II).
本发明的另一个目的是提供一条高 β-选择性的采用化学式 σιι)所示 化合物对化学式 (II)所示化合物的直接 Mannich加成反应的方法。 Another object of the present invention is to provide a high β-selective method for direct Mannich addition of a compound of the formula (II) using a compound of the formula σιι).
另外, 本发明还提供了该 Mannich反应的最佳反应条件。
本发明提供了一条制备化学式 σ)所示的培南类抗生素中间体的方 法, 由反应式 7中所示的步骤构成。 In addition, the present invention also provides optimum reaction conditions for the Mannich reaction. The present invention provides a process for preparing a penicillin antibiotic intermediate represented by the chemical formula σ), which comprises the steps shown in Reaction Scheme 7.
本发明中, 化学式 σ)所示化合物简称为化合物 σ), 其他化合物也采 用相应的简称。 In the present invention, the compound represented by the chemical formula σ) is abbreviated as the compound σ), and the other compounds are also referred to as corresponding abbreviations.
本发明中, 下列物质用其相应的简称代替: In the present invention, the following substances are replaced by their corresponding abbreviations:
TMS: 三甲基硅基; TMS: trimethylsilyl;
TBS: 叔丁基二甲基硅基; TBS: tert-butyldimethylsilyl;
ΡΝΒ : 对硝基苄基; ΡΝΒ : p-nitrobenzyl;
Me: 甲基; Me: methyl;
Et: 乙基; Et: ethyl;
Bz: 苯甲酰基; Bz: benzoyl;
Ac: 乙酰基; Ac: acetyl group;
Bn: 苄基; Bn: benzyl;
Allyl: 烯丙基。 Allyl: allyl.
在反应式 7中, R1代表的官能团包括但不限于: 甲基 (Me)、 乙基 (Et)、 对硝基苄基 (PNB)、 苄基 (Bn)、 烯丙基 (Allyl)、 4-氯苄基、 2-硝基苄基、 3- 硝基苄基、 4-甲氧基苄基; In Reaction Scheme 7, the functional group represented by R 1 includes, but is not limited to, methyl (Me), ethyl (Et), p-nitrobenzyl (PNB), benzyl (Bn), allyl (Allyl), 4-chlorobenzyl, 2-nitrobenzyl, 3-nitrobenzyl, 4-methoxybenzyl;
R2代表的官能团包括但不限于: 乙酰基 (Ac)、 苯甲酰基 (Bz); The functional group represented by R 2 includes, but is not limited to, acetyl (Ac), benzoyl (Bz);
R2代表的官能团包括但不限于: 三甲基硅基 (TMS)、 叔丁基二甲基硅 基 (TBS)。 The functional groups represented by R 2 include, but are not limited to, trimethylsilyl (TMS), tert-butyldimethylsilyl (TBS).
化学式 (III)所示化合物可通过现有方法简便合成得到。 The compound of the formula (III) can be easily synthesized by a conventional method.
反应式 7中的内容实质上包含两个步骤: The content in Equation 7 consists essentially of two steps:
步骤 h 化学式 (Π)所示化合物与化学式 σιι)所示化合物反应得到化 学式 (XVI)所示化合物; Step h The compound of the formula (Π) is reacted with a compound of the formula σιι) to obtain a compound of the formula (XVI);
步骤 2 : 由化学式 (XVI)所示化合物制备化学式 所示化合物, 即 β-
甲基培南类抗生素中间体。 Step 2: The compound represented by the chemical formula (XVI) is prepared, that is, β- Methylpenic antibiotic intermediate.
其中步骤 1和步骤 2根据如下反应条件进行: Steps 1 and 2 are carried out according to the following reaction conditions:
对于步骤 1, 反应可以在多种已知的路易斯 (Lewis) 酸催化的直接 曼奇尼 (Mannich) 反应的条件下进行。 反应完成后, 可采用多种方法进 行后处理。 For step 1, the reaction can be carried out under a variety of known Lewis acid catalyzed direct Mannich reactions. After the reaction is completed, various methods can be used for post treatment.
所述用于 Mannich反应的 Lewis酸可以为现有用于 Mannich反应的 任意种酸, 包括但不限于四氯化钛 (TiCl4)、 四溴化钛 (TiBr4)、 四氯化硅 (SiCl4)、三氯化镧 (LaCl3)、氯化锌 (ZnCl2)、溴化锌 (ZnBr2)、氯化镁 (MgCl2)、 三溴化硼 (BBr3)、 氯化铜 (CuCl2)、 三氟甲磺酸铜 (Cu(OTf)2)、 三氟甲磺酸 亚铜 (CuOTf)、 碘化亚铜 (Cul)、 三氯化硼 (BC13)等, 优选采用相对较便宜 的四氯化钛 (TiCl4)。 The Lewis acid used in the Mannich reaction may be any of the existing acids used in the Mannich reaction, including but not limited to titanium tetrachloride (TiCl 4 ), titanium tetrabromide (TiBr 4 ), silicon tetrachloride (SiCl 4 ). ), lanthanum trichloride (LaCl 3 ), zinc chloride (ZnCl 2 ), zinc bromide (ZnBr 2 ), magnesium chloride (MgCl 2 ), boron tribromide (BBr 3 ), copper chloride (CuCl 2 ), Copper triflate (Cu(OTf) 2 ), cuprous triflate (CuOTf), cuprous iodide (Cul), boron trichloride (BC1 3 ), etc., preferably using relatively inexpensive four Titanium chloride (TiCl 4 ).
Lewis 酸与化学式 (II)所示化合物的摩尔比为 0.8~3.0 : 1, 优选为 1.0-1.5: l o 如果采用较少的 Lewis酸, 反应无法进行完全。 The molar ratio of the Lewis acid to the compound of the formula (II) is 0.8 to 3.0:1, preferably 1.0 to 1.5: l o If less Lewis acid is used, the reaction cannot be completed.
步骤 1的反应中还存在路易斯 (Lewis) 碱。 所述 Lewis碱可以为现 有用于 Mannich反应的任意种碱, 包括但不限于三乙胺、 二异丙基乙胺、 三正丁胺、 四甲基乙二胺、 4-甲基吗啉、 1,8-二氮杂双环 [5.4.0]十一碳 -7- 烯、 1,4-二氮杂二环 [2.2.2]辛垸、 4-二甲胺基吡啶、 N-甲基吡咯垸、 N-甲 基哌啶、 二乙胺、 二异丙胺、 吡咯、 哌啶、 六甲基磷酰三胺、 吡啶、 3- 甲基吡啶及它们的组合。 优选采用其中的三级胺。 A Lewis base is also present in the reaction of step 1. The Lewis base may be any of the bases currently used in the Mannich reaction, including but not limited to triethylamine, diisopropylethylamine, tri-n-butylamine, tetramethylethylenediamine, 4-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diazabicyclo[2.2.2]octane, 4-dimethylaminopyridine, N-methyl Pyrrolizine, N-methylpiperidine, diethylamine, diisopropylamine, pyrrole, piperidine, hexamethylphosphoric triamide, pyridine, 3-methylpyridine, and combinations thereof. It is preferred to use a tertiary amine therein.
Lewis 碱与化学式 (II)所示化合物的摩尔比为 1.2~4.0 : 1, 优选为 The molar ratio of the Lewis base to the compound of the formula (II) is from 1.2 to 4.0:1, preferably
1.8-2.5: 1。 1.8-2.5: 1.
作为优选的技术方案, 步骤 1的反应通常为: 将化学式 所示化合 物溶解于有机溶剂中, 冷却, 然后加入 Lewis酸及 Lewis碱, 搅拌, 加入 化学式 (Π)所示化合物, 然后反应直至终点。 As a preferred technical solution, the reaction of the step 1 is usually carried out by dissolving the compound of the formula in an organic solvent, cooling, then adding a Lewis acid and a Lewis base, stirring, adding a compound of the formula (Π), and then reacting until the end.
所述溶剂包括二氯甲垸、 1,2-二氯乙垸、 甲苯、 乙腈、 四氢呋喃、 甲 基叔丁基醚、 2-甲基四氢呋喃或它们的组合。 优选采用二氯甲垸、 1,2-二 氯乙垸或它们的组合。 The solvent includes methylene chloride, 1,2-dichloroacetonitrile, toluene, acetonitrile, tetrahydrofuran, methyl t-butyl ether, 2-methyltetrahydrofuran or a combination thereof. Preferably, methylene chloride, 1,2-dichloroethane or a combination thereof is used.
所述溶剂的用量相对于化学式 (Π)所示化合物用量为 8~30 mL/g (即 每克化学式 (Π)所示化合物使用溶剂 8~30 mL) , 优选为 12~20 mL/g。 The solvent is used in an amount of 8 to 30 mL/g based on the compound of the formula (Π) (i.e., 8 to 30 mL of the solvent per gram of the compound represented by the formula (Π), preferably 12 to 20 mL/g.
化学式 (III)所示化合物与化学式 (Π)所示化合物的摩尔比为 1.0~2.0 :
1, 优选为 1.2~1.5: 1。 The molar ratio of the compound of the formula (III) to the compound of the formula (Π) is 1.0 to 2.0: 1, preferably 1.2 to 1.5: 1.
步骤 1的反应温度为 -60~10°C, 优选 -30~0°C。 The reaction temperature in the step 1 is -60 to 10 ° C, preferably -30 to 0 ° C.
具体来说, 所述 Lewis酸及 Lewis碱加入的合适温度为 -60~0°C, 优 选为 -50— 30°C。 化学式 (II)所示化合物加入前合适的搅拌时间应该为 10~60分钟, 优选 20~30分钟。 化学式 (II)所示化合物加入的合适温度为 -60~0°C, 优选 -40〜- 20°C。 反应的合适温度为 -40~10°C, 优选 -20~0°C。 反 应在较低的温度下将会进行的非常缓慢。 合适的反应时间应该在 4 小时 内, 如果可能, 反应应该在 2.5小时内完成。 较长的反应时间会导致生成 更多的杂质并降低产率。 Specifically, a suitable temperature for the addition of the Lewis acid and the Lewis base is -60 to 0 ° C, preferably -50 to 30 ° C. The appropriate stirring time before the addition of the compound of the formula (II) should be 10 to 60 minutes, preferably 20 to 30 minutes. A suitable temperature for the addition of the compound of the formula (II) is -60 to 0 ° C, preferably -40 to 20 ° C. A suitable temperature for the reaction is -40 to 10 ° C, preferably -20 to 0 ° C. The reaction will proceed very slowly at lower temperatures. The appropriate reaction time should be within 4 hours and, if possible, the reaction should be completed within 2.5 hours. Longer reaction times result in more impurities and lower yields.
反应完成后, 采用水溶液如氯化钠水溶液、 碳酸氢钠水溶液、 磷酸二 氢钠水溶液、磷酸二氢钾水溶液、 氯化镁水溶液、 氯化钙水溶液或纯水淬 灭反应, 优选采用纯水。 其中, 所述水溶液的浓度为常用的淬灭溶液的浓 度, 优选溶质的质量百分比可以为 5% ~ 25%。 After completion of the reaction, the reaction is quenched with an aqueous solution such as aqueous sodium chloride solution, aqueous sodium hydrogencarbonate solution, aqueous sodium dihydrogen phosphate solution, aqueous potassium dihydrogen phosphate solution, aqueous magnesium chloride solution, aqueous calcium chloride solution or purified water, preferably using pure water. Wherein, the concentration of the aqueous solution is a concentration of a common quenching solution, and preferably the mass percentage of the solute may be 5% to 25%.
淬灭溶液的用量相对于化学式 (Π)所示化合物用量为 3~30 mL/g, 优 选为 5~10 mL/g。 The amount of the quenching solution is 3 to 30 mL/g, preferably 5 to 10 mL/g, based on the compound of the formula (Π).
步骤 1所得的化学式 (XVI)所示化合物产品可以直接将粗品用于下一 步反应, 也可进一步纯化后使用, 优选采用甲醇、 甲醇 -水、 乙醇、 乙醇- 水、 丙酮、 丙酮 -水、 乙腈、 异丙醇、 正己垸、 正庚垸、 甲苯、 石油醚等 溶剂通过重结晶纯化, 更优选采用甲醇-水进行重结晶纯化。 重结晶溶剂 的用量相对于化学式 (II)所示化合物用量为 3~20 mL/g,优选为 4~8 mL/g。 采用较多的溶剂会降低产率。 The compound of the formula (XVI) obtained in the step 1 can be directly used for the next reaction, or can be further purified, preferably using methanol, methanol-water, ethanol, ethanol-water, acetone, acetone-water, acetonitrile. Solvents such as isopropanol, n-hexanol, n-glycol, toluene, petroleum ether, etc. are purified by recrystallization, more preferably by recrystallization from methanol-water. The amount of the recrystallization solvent is from 3 to 20 mL/g, preferably from 4 to 8 mL/g, based on the compound of the formula (II). Using more solvent will reduce the yield.
对于步骤 2, 反应可以在多种采用酸脱除叔丁基二甲基硅基或三甲基 硅基保护的反应条件下进行, 反应完成后, 可采用多种方法进行后处理。 For the step 2, the reaction can be carried out under various reaction conditions in which the acid is removed by the removal of the t-butyldimethylsilyl group or the trimethylsilyl group. After the completion of the reaction, various methods can be used for the post treatment.
所述的用于脱除叔丁基二甲基硅基或三甲基硅基保护的酸包括盐酸 (HC1)、 硫酸 (H2S04)、 甲基磺酸 (MeS03H)、 苯磺酸 (PhS03H)和三氟乙酸, 优选采用盐酸。 The acid used for removing tert-butyldimethylsilyl or trimethylsilyl protection includes hydrochloric acid (HC1), sulfuric acid (H 2 S0 4 ), methanesulfonic acid (MeS0 3 H), benzenesulfonate. Acid (PhS0 3 H) and trifluoroacetic acid, preferably hydrochloric acid.
所述用于脱除叔丁基二甲基硅基或三甲基硅基保护的盐酸的浓度为 0.5-4 mol/L, 优选为 1.0~2.0 mol/L。 The concentration of the hydrochloric acid for protecting the tert-butyldimethylsilyl or trimethylsilyl group is 0.5-4 mol/L, preferably 1.0 to 2.0 mol/L.
步骤 2的反应在溶剂中进行, 所述溶剂选自乙腈 -水、 甲醇 -水、 丙酮 -水、 四氢呋喃 -水等的混合溶剂, 其中有机溶剂的体积浓度范围为 40% ~
80%, 优选采用体积浓度为 40% 〜 80%乙腈含量的乙腈-水溶液作为反应 溶剂。 溶剂的用量相对于为化学式 (XVI)所示化合物用量为 4~15 mL/g, 优选为 6~10 mL/g。 The reaction of the step 2 is carried out in a solvent selected from the group consisting of a mixed solvent of acetonitrile-water, methanol-water, acetone-water, tetrahydrofuran-water, etc., wherein the volume concentration of the organic solvent ranges from 40% to ~ 80%, preferably an acetonitrile-water solution having a volume concentration of 40% to 80% acetonitrile is used as a reaction solvent. The amount of the solvent used is 4 to 15 mL/g, preferably 6 to 10 mL/g, based on the compound of the formula (XVI).
步骤 2反应合适的温度为 0~30°C, 优选为 15~20°C。 The suitable temperature for the step 2 reaction is 0 to 30 ° C, preferably 15 to 20 ° C.
与以往的路线相比, 本发明提供的制备方法有明显的优势。反应步骤 大大縮短, 与以往从化学式 σι)所示化合物制备化学式 σ)所示化合物需要 Compared with the prior route, the preparation method provided by the present invention has obvious advantages. The reaction step is greatly shortened, and it is required to prepare a compound represented by the chemical formula σ) from the compound represented by the chemical formula σι)
5~7步相比, 本发明中所用的制备方法只需要 2步, 因此反应周期大大縮 短, 节约了人工成本, 用于商业化生产的设备投资减少, 所用溶剂的种类 及用量减少, 对环境的污染也相对减轻, 同时节约了工厂的生产成本。 本 发明的制备方法反应原料易得,所得产物的选择性和收率相对于现有方法 都有明显提高。 具体实施方式 Compared with the 5~7 steps, the preparation method used in the present invention requires only 2 steps, so the reaction cycle is greatly shortened, labor costs are saved, equipment investment for commercial production is reduced, and the types and amounts of solvents used are reduced. The pollution is also relatively reduced, while saving the production costs of the factory. The preparation method of the present invention is easily obtained as a raw material, and the selectivity and yield of the obtained product are remarkably improved as compared with the prior art. detailed description
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别 指明, 实施例中所用的试剂均为常规市售试剂, 实施例中所用的技术手段 为本领域技术人员所熟知的常规手段。 The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention. Unless otherwise specified, the reagents used in the examples are conventional commercially available reagents, and the technical means used in the examples are conventional means well known to those skilled in the art.
实施例 1 Example 1
( 1 ) 制备化学式 (XVIa)所示化合物 (1) Preparation of a compound of the formula (XVIa)
化合物 (Ilia)参考文献 US 4644061A1 ( 1987 ) 合成。 Compound (Ilia) is synthesized by reference to US 4644061 A1 (1987).
化学式 (Ilia)所示化合物(188 g)溶解于二氯甲垸(1500 mL)中, 冷却至 -40°C, 缓慢加入四氯化钛 (104 g)的二氯甲垸 (300 mL)溶液, 所得的黄色 浆状物继续搅拌 30分钟。缓慢加入三乙胺 (105 g), 然后反应液升至 -20°C 并继续搅拌 1小时, 然后缓慢加入 4AA (150 g)的二氯甲垸 (300 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至 5°C, 然后用水 (750 mL)淬灭。 静置分层, 分出二氯甲垸相, 滤过一层硅胶 (75 g), 然后浓縮。 HPLC表 明反应体系中产物的 β/α 比为 8.8: 1。 剩余物用甲醇 (300 mL)洗料, 过滤
得化学式 (XVIa)所示化合物, 液相纯度为 80%, β/α 比为 30:1, 直接用于 下一步反应。 The compound of formula (Ilia) (188 g) was dissolved in dichloromethane (1500 mL), cooled to -40 ° C, and titanium tetrachloride (104 g) in dichloromethane (300 mL) was slowly added. The resulting yellow slurry was stirred for a further 30 minutes. Triethylamine (105 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (150 g) in dichloromethane (300 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to 5 ° C then quenched with water (750 mL). The layers were allowed to stand, the methylene chloride phase was separated, and a layer of silica gel (75 g) was filtered and concentrated. HPLC showed the product in the reaction system to have a β/α ratio of 8.8:1. The residue was washed with methanol (300 mL), filtered The compound of the formula (XVIa) has a liquid phase purity of 80% and a β/α ratio of 30:1, which is directly used in the next reaction.
Ή NMR (400 MHz, CDC13): δ 8.22 (d, J= 8.7 Hz, 2H), 7.51 (d, J= 8.6 Hz, 2H), 6.10 (s, IH), 5.33 (s, 2H), 4.18-4.12 (m, IH), 3.92-3.86 (m, 2H), 2.94 (d,J=4.3 Hz, IH), 1.17-1.15 (m, 6H), 0.83 (s, 9H), 0.04 (d, J= 5.2 Hz, 6H)。 NMR NMR (400 MHz, CDC1 3 ): δ 8.22 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 8.6 Hz, 2H), 6.10 (s, IH), 5.33 (s, 2H), 4.18 -4.12 (m, IH), 3.92-3.86 (m, 2H), 2.94 (d, J=4.3 Hz, IH), 1.17-1.15 (m, 6H), 0.83 (s, 9H), 0.04 (d, J = 5.2 Hz, 6H).
(2) 制备化学式 (la)所示化合物 (2) Preparation of a compound of the formula (la)
化学式 (XVIa)所示化合物 (51 g)悬浮于乙腈体积百分比为 40%的乙腈 The compound of formula (XVIa) (51 g) is suspended in acetonitrile with 40% by volume of acetonitrile.
-水溶液 (300 mL)中,在 15~20°C下加入 1NHC1(100 mL)。反应在 15~20 °C 下搅拌直至反应完全。 加入 300 mL乙酸乙酯, 用饱和碳酸氢钠调节水相 的 pH到 6~7。 静置分出有机相, 用 150 mL饱和食盐水洗涤, 浓縮, 加 入 150 mL甲苯析晶, 过滤得到化学式 (la)所示化合物 (36 g,产率 92.3%), 液相纯度>97%。 In an aqueous solution (300 mL), 1NHC1 (100 mL) was added at 15 to 20 °C. The reaction was stirred at 15 to 20 ° C until the reaction was complete. Add 300 mL of ethyl acetate and adjust the pH of the aqueous phase to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 150 mL of brine, concentrated, 150 mL of toluene, and filtered to give the compound of formula (la) (36 g, yield 92.3%), liquid phase purity >97% .
lR NMR (400 MHz, CDC13): δ 8.25 (d, J= 8.7 Hz, 2H), 7.53 (d, J= 8.7lR NMR (400 MHz, CDC1 3 ): δ 8.25 (d, J = 8.7 Hz, 2H), 7.53 (d, J = 8.7
Hz, 2H), 6.25 (br, IH), 5.35 (s, 2H), 4.13-4.17 (m, IH), 3.88 (dd, J= 8.5, 2.0Hz, 2H), 6.25 (br, IH), 5.35 (s, 2H), 4.13-4.17 (m, IH), 3.88 (dd, J= 8.5, 2.0
Hz, IH), 3.62 (dd, J= 8.3, 7.2 Hz, IH), 2.96 (d, J= 4.5 Hz, IH), 2.89 (dd, JHz, IH), 3.62 (dd, J= 8.3, 7.2 Hz, IH), 2.96 (d, J= 4.5 Hz, IH), 2.89 (dd, J
= 6.0, 2.0 Hz, IH), 1.30 (d, J = 8.4 Hz, 3H), 1.20 (d, J= 8.4 Hz, 3H)。 = 6.0, 2.0 Hz, IH), 1.30 (d, J = 8.4 Hz, 3H), 1.20 (d, J = 8.4 Hz, 3H).
实施例 2 Example 2
(1) 制备化学式 (nib)所示化合物 (1) Preparation of a compound of the formula (nib)
在约 20 °C下加入对氯苄醇 (100 g), 3-氧代戊酸甲酯 (100 g)和甲苯 Add p-chlorobenzyl alcohol (100 g), methyl 3-oxopentanoate (100 g) and toluene at about 20 °C
(300 mL), 加热至回流, 采用常压蒸馏装置蒸出溶剂至体系温度升至 150
°°CC。。 重重复复 33~~44次次,, 所所得得化化学学式式 ((XXVVIIIIbb))所所示示化化合合物物的的粗粗品品直直接接用用于于下下一一步步 反反应应。。 (300 mL), heated to reflux, and the solvent was distilled off using an atmospheric distillation apparatus until the temperature of the system rose to 150. ° ° CC. . Repeatingly repeating 33~~44 times, the obtained crude chemical product of the chemical compound formula ((XXVVIIIIbb)) is directly used for the next step. Step reaction should be. .
在在约约 2200 °°CC下下加加入入上上述述化化学学式式 ((XXVVIIIIbb))所所示示化化合合物物的的粗粗品品,, 甲甲苯苯 ((330000 mmLL))和和三三乙乙胺胺 ((3355..44 gg)),, 然然后后滴滴加加对对十十二二垸垸基基苯苯磺磺酰酰叠叠氮氮 ((227700..44 gg))。。 滴滴毕毕,, 5 自自然然恢恢复复到到室室温温反反应应 55小小时时。。 反反应应体体系系浓浓縮縮至至约约 220000~~330000 mmLL,, 然然后后加加入入 正正庚庚垸垸 ((550000 mmLL)),, 冰冰水水浴浴冷冷却却搅搅拌拌约约 55小小时时。。 过过滤滤,, 滤滤饼饼用用正正庚庚垸垸洗洗涤涤,, 干干燥燥得得到到化化学学式式 ((nniibb))所所示示化化合合物物((112266 gg,, 产产率率 6677%%)),, 液液相相纯纯度度 9999..44%%。。 The crude crude product of the chemical compound represented by the above-mentioned chemical formula ((XXVVIIIIbb)) is added at about 2200 ° ° CC, toluene benzene ((330000 mm LL) And triethyltriethylamine ((3355..44 gg)), and then post-drip plus p-dodecyldiphenylbenzenesulfonyl-lacide azide nitrogen (227700 ..44 gg)). . After the drop is completed, 5 will return to the room temperature and the reaction should be 55 hours. . The reaction system is concentrated and concentrated to about 220000~~330000 mmLL, and then added to the positive gengbeng ((550000 mmLL)), and the ice-cold water bath is cooled by cooling and stirred. Mix about 55 hours. . After filtering through the filter, the filter cake is washed and washed with Zheng Geng Geng, dried and dried to obtain the chemical compound represented by the chemical formula ((nniibb)) ((112266) Gg,, yield yield: 6677%%)), liquid-liquid phase purity purity 9999..44%%. .
llRR NNMMRR ((440000 MMHHzz,, CCDDCC1133)):: δδ 77..3366 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 77..3300 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 55..2222 ((ss,, 22HH)),, 22..8866 ((qq,, JJ == 77..33 HHzz,, 22HH)),, 11..1144 ((tt,, JJ == 77..33 HHzz,, 33HH))。。 l l RR NNMMRR ((440000 MMHHzz,, CCDDCC11 33 )):: δδ 77..3366 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 77..3300 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 55..2222 ((ss,, 22HH)),, 22..8866 ((qq,, JJ == 77..33 HHzz,, 22HH) ),, 11..1144 ((tt,, JJ == 77..33 HHzz,, 33HH)). .
化化学学式式 ((IIllllbb))所所示示化化合合物物 ((2255 溶溶解解于于二二氯氯甲甲垸垸 ((228800 mmLL))中中,, 冷冷却却至至 1155 --4400°°CC,, 缓缓慢慢加加入入四四氯氯化化钛钛 ((1133..22 gg)),, 所所得得的的黄黄色色浆浆状状物物继继续续搅搅拌拌 3300分分钟钟。。 Chemical compound formula ((IIllllbb)) shown in the chemical compound ((2255 dissolved in dichlorochloromethylformamidine ((228800 mmLL)), cold cooling to 1155 --4400 ° ° CC,, slowly and slowly added to the titanium tetrachloride titanium chloride ((1133..22 gg)), the obtained yellow-yellow color slurry Continue to stir and stir for 3,300 minutes.
缓缓慢慢加加入入三三乙乙胺胺 ((1144..11 gg)) ,, 然然后后反反应应液液升升至至 --2200°°CC并并继继续续搅搅拌拌 11小小时时,, 然然后后 缓缓慢慢加加入入 44AAAA ((2200 gg))的的二二氯氯甲甲垸垸 ((4400 mmLL))溶溶液液。。 在在 --2200°°CC下下搅搅拌拌 33小小时时后后,, 将将反反应应物物升升温温至至室室温温,, 然然后后用用水水 ((115500 mmLL))淬淬灭灭。。 静静置置分分层层,, 分分出出二二氯氯甲甲垸垸 相相,,然然后后浓浓縮縮。。剩剩余余物物用用硅硅胶胶柱柱色色谱谱纯纯化化得得化化学学式式 ((XXVVIIbb))所所示示化化合合物物 ((1177..00 2200 gg,, 4499%% 产产率率)),, ββ//αα 比比为为 77..33 :: 11。。 Slowly and slowly add tributyl triethylamine ((1144..11 gg)), and then the reaction should be raised to -2200 ° ° CC and continue to stir and stir. At 11 hours, then slowly and slowly add 44AAAA ((2200 gg)) of dichlorochloromethane ((4400 mmLL)) solution. . After stirring for 33 hours at -2200 ° ° CC, the reaction product will be warmed to room temperature, and then water ((115500 mm LL)) Quenching and extinction. . The layer was layered quietly, and the phase of dichlorochloromethane was separated out, and then concentrated and concentrated. . The remaining residue was purified by column chromatography using silica gel column chromatography to obtain the chemical compound represented by the chemical formula ((XXVVIIbb)) ((1177..00 2200 gg, 4499) %% yield rate)), ββ//αα ratio is 77..33::11. .
! !HH NNMMRR (( ββ异异构构体体)) ((440000 MMHHzz,, CCDDCC1133)):: δδ 77..3355 ((άά,, JJ == 88..55 HHzz,, 22ΗΗ)),, 77..3300 ((dd,, JJ == 88..44 HHzz,, 22HH)),, 55..9922 ((ss,, 11HH)),, 55..2211 ((dd,, JJ == 22..11HHzz,, 22HH)),, 44..1199--44..1144 ((mm,, 11HH)),, 33..9922--33..8877 ((mm,, 22HH)),, 22..9955 ((dddd,, JJ == 44..00,, 11..88 HHzz,, 11HH)),, 11..1188--11..1155 ((mm,, 66HH)),, 00..8844 ((ss,, 99HH)),, 00..0044 ((dd,, JJ == 66..00 HHzz,, 66HH))。。 !! HH NNMMRR ((ββ isomer thereof iso isomers)) ((440000 MMHHzz ,, CCDDCC11 33)) :: δδ 77..3355 ((άά ,, JJ == 88..55 HHzz ,, 22ΗΗ)) ,, 77..3300 ((dd,, JJ == 88..44 HHzz,, 22HH)),, 55..9922 ((ss,, 11HH)),, 55..2211 ((dd,, JJ == 22..11HHzz,, 22HH)),, 44..1199--44..1144 ((mm,, 11HH)),, 33..9922--33..8877 ((mm,, 22HH) ),, 22..9955 ((dddd,, JJ == 44..00,, 11..88 HHzz,, 11HH)),, 11..1188--11..1155 ((mm,, 66HH) ),, 00..8844 ((ss,, 99HH)),, 00..0044 ((dd,, JJ == 66..00 HHzz,, 66HH)). .
2255 *
化学式 (XVIb)所示化合物 (15 g)悬浮于乙腈体积百分比为 40%的乙腈 -水溶液(100 mL)中,在 15~20°C下加入 IN HCl (36mL)。反应在 15~20 °C 下搅拌直至反应完全。 加入 120 mL乙酸乙酯, 用饱和碳酸氢钠调节水相 的 pH到 6~7。 静置分出有机相, 用 45 mL饱和食盐水洗涤, 浓縮, 硅胶 柱色谱纯化得到化学式 (lb)所示化合物(11.4 g, 100% 产率), β/α 比为 7.3:1。 2255 * The compound of the formula (XVIb) (15 g) was suspended in an acetonitrile-water solution (100 mL) of 40% by volume of acetonitrile, and IN HCl (36 mL) was added at 15 to 20 °C. The reaction was stirred at 15 to 20 ° C until the reaction was completed. 120 mL of ethyl acetate was added and the pH of the aqueous phase was adjusted to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 45 mL of brine, concentrated, and purified by silica gel column chromatography to give the compound of formula (lb) (11.4 g, 100% yield) with a ratio of 7.3:1.
!H NMR (β异构体) (400 MHz, CDC13): δ 7.37 (ά, J = 8.4 Hz, 2Η), ! H NMR (β-isomer) (400 MHz, CDC1 3) : δ 7.37 (ά, J = 8.4 Hz, 2Η),
7.29 (d, J= 8.4 Hz, 2H), 6.74 (br, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J= 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H), 2.85 (dd, J= 6.6, 1.8 Hz, 1H),7.29 (d, J= 8.4 Hz, 2H), 6.74 (br, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J= 6.4, 2.1 Hz, 1H), 3.69 -3.75 (m, 1H), 2.85 (dd, J= 6.6, 1.8 Hz, 1H),
2.67 (brs, 1H), 1.22 (d, J= 6.3 Hz, 3H), 1.17 (d,J= 6.3 Hz, 3H)。 2.67 (brs, 1H), 1.22 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H).
实施例 3 Example 3
(1) 制备化学式 (Hie)所示化合物 (1) Preparation of a compound of the formula (Hie)
在约 15 °C下加入 3-氧代戊酸甲酯 (30 g),甲苯 (150 mL)和三乙胺 (11.6 g), 然后滴加对十二垸基苯磺酰叠氮 (89.1 g 滴毕, 自然恢复到室温反 应 5 小时。 反应体系浓縮至无馏分, 粗品用硅胶柱色谱纯化得到化学式 (IIIc)所示化合物 (33.8 g, 产率 94%), 液相纯度 98.5%。 Methyl 3-oxopentanoate (30 g), toluene (150 mL) and triethylamine (11.6 g) were added at about 15 ° C, then p-dodecylbenzenesulfonyl azide (89.1 g) was added dropwise. After the dropwise addition, the mixture was naturally returned to room temperature for 5 hours. The reaction system was concentrated to a fraction. The crude product was purified by silica gel column chromatography to give the compound of formula (IIIc) (33.8 g, yield 94%), and the liquid phase purity was 98.5%.
1ΊΆ NMR (400 MHz, CDC13): δ 3.83 (s, 3H), 2.86 (q, J = 7.3 Hz, 2H), 1 Ί Ά NMR (400 MHz, CDC1 3): δ 3.83 (s, 3H), 2.86 (q, J = 7.3 Hz, 2H),
1.14 (t,J= 7.3 Hz, 3H 1.14 (t, J = 7.3 Hz, 3H
(2) 制备化学式 (XVIc)所示化合物
化学式 (IIIc)所示化合物(14.1 g)溶解于二氯甲垸 (280 mL)中, 冷却至 -40°C, 缓慢加入四氯化钛 (13.2 g), 所得的黄色浆状物继续搅拌 30分钟。 缓慢加入三乙胺 (14.1 g), 然后反应液升至 -20°C并继续搅拌 1小时, 然后 缓慢加入 4AA (20 g)的二氯甲垸 (40 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至室温, 然后用水 (150 mL)淬灭。 静置分层, 分出二氯甲垸 相,然后浓縮。剩余物用硅胶柱色谱纯化得化学式 (XVIc)所示化合物 (11.5 g, 43% 产率), β/α 比为 4.2: 1。 (2) Preparation of a compound of the formula (XVIc) The compound of the formula (IIIc) (14.1 g) was dissolved in dichloromethane (280 mL), cooled to -40 ° C, titanium tetrachloride (13.2 g) was slowly added, and the resulting yellow slurry was stirred continuously. minute. Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, and then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to EtOAc EtOAc. The layers were allowed to stand, the methylene chloride phase was separated, and then concentrated. The residue was purified by silica gel column chromatography toield of compound of formula (XVIc) (11.5 g, 43% yield). The ratio of β/α was 4.2:1.
^ NMR ( β异构体)(400 MHz, CDC13): δ 5.97 (brs, 1Η), 4.17-4.19 (m, 1H), 3.85-3.94 (m, 1H), 3.84 (s, 3H), 2.92 (dd, J = 3.9, 1.8 Hz, 1H), 1.17-1.20 (m, 6H), 0.88 (s, 9H), 0.07 (d, J= 6.0 Hz, 6H)。 ^ NMR (β isomer) (400 MHz, CDC1 3 ): δ 5.97 (brs, 1Η), 4.17-4.19 (m, 1H), 3.85-3.94 (m, 1H), 3.84 (s, 3H), 2.92 (dd, J = 3.9, 1.8 Hz, 1H), 1.17-1.20 (m, 6H), 0.88 (s, 9H), 0.07 (d, J = 6.0 Hz, 6H).
( 3 ) 制备化学式 (Ic)所示化合物 (3) Preparation of a compound of the formula (Ic)
化学式 (XVIa)所示化合物 (10 g)悬浮于乙腈体积百分比为 40%的乙腈 The compound of formula (XVIa) (10 g) was suspended in acetonitrile with 40% by volume of acetonitrile.
-水溶液 (80 mL)中, 在 15~20。C下加入 IN HC1 (30 mL)。 反应在 15-20。C 下搅拌直至反应完全。 加入 100 mL乙酸乙酯, 用饱和碳酸氢钠调节水相 的 pH到 6~7。 静置分出有机相, 用 50 mL饱和食盐水洗涤, 浓縮, 硅胶 柱色谱纯化得到化学式 (lb)所示化合物 (7.16 g, 100% 产率), β/α 比为 4.2: 1。 - In an aqueous solution (80 mL), at 15-20. Add IN HC1 (30 mL) to C. The reaction is at 15-20. Stir under C until the reaction is complete. Add 100 mL of ethyl acetate and adjust the pH of the aqueous phase to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 50 mL of brine, concentrated, and purified by silica gel column chromatography to give the compound of formula (lb) (7.16 g, 100% yield). The ratio of β/α was 4.2:1.
^ NMR ( β异构体)(400 MHz, CDC13): δ 6.65 (brs, 1Η), 4.04-4.09 (m, 1H), 3.69 (s, 3H), 3.80 (dd, J= 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H), 2.85 (dd J = 6.6, 1.8 Hz, 1H), 2.65 (brs, 1H), 1.24 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H) o
实施例 4 ^ NMR (β isomer) (400 MHz, CDC1 3 ): δ 6.65 (brs, 1Η), 4.04-4.09 (m, 1H), 3.69 (s, 3H), 3.80 (dd, J= 6.4, 2.1 Hz , 1H), 3.69-3.75 (m, 1H), 2.85 (dd J = 6.6, 1.8 Hz, 1H), 2.65 (brs, 1H), 1.24 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H) o Example 4
( 1 ) 制备化学式 (Hid)所示化合物 (1) Preparation of a compound of the formula (Hid)
在约 25°C下加入邻硝基苄醇 (107 g), 3-氧代戊酸甲酯 (100 g)和甲苯 Add o-nitrobenzyl alcohol (107 g), methyl 3-oxopentanoate (100 g) and toluene at about 25 °C
(300 mL) , 加热至回流, 采用常压蒸馏装置蒸出溶剂至体系温度升至 150 °C。 重复 3~4次, 所得化学式 (XVIId)所示化合物的粗品直接用于下一步 反应。 (300 mL), heated to reflux, and the solvent was distilled off using an atmospheric distillation apparatus until the temperature of the system was raised to 150 °C. The crude product of the obtained compound of the formula (XVIId) was directly used in the next reaction 3 to 4 times.
在约 25 °C下加入上述化学式 (XVIId)所示化合物的粗品, 甲苯 (300 mL)和三乙胺 (35.4 g), 然后滴加对十二垸基苯磺酰叠氮 (270.4 g)。 滴毕, 自然恢复到室温反应 5小时。 反应体系浓縮至约 200~300 mL, 然后加入 正庚垸 (500 mL), 冰水浴冷却搅拌约 1小时。 过滤, 滤饼用正庚垸洗涤, 干燥得到化学式 (Hid)所示化合物(151 g, 产率 78%) , 液相纯度 99.6%。 The crude compound of the above formula (XVIId), toluene (300 mL) and triethylamine (35.4 g) were added at about 25 ° C, then p-dodecylbenzenesulfonyl azide (270.4 g) was added dropwise. After the completion of the dropwise addition, the reaction was naturally returned to room temperature for 5 hours. The reaction system was concentrated to about 200 to 300 mL, then n-glycol (500 mL) was added, and the mixture was cooled and cooled in an ice water bath for about 1 hour. After filtration, the filter cake was washed with n-glycol and dried to give a compound of the formula (Hd) (151 g, yield 78%), and the liquid phase purity was 99.6%.
!H NMR (400 MHz, CDC13): δ 8.08-8.18 (m, 1Η), 7.64-7.75 (m, 1H), 7.46-7.59 (m, 2H), 5.67 (s, 2H), 2.86 (q, J = 7.3 Hz, 2H), 1.15 (t, J = 7.3 Hz, 3H) o !H NMR (400 MHz, CDC1 3 ): δ 8.08-8.18 (m, 1Η), 7.64-7.75 (m, 1H), 7.46-7.59 (m, 2H), 5.67 (s, 2H), 2.86 (q, J = 7.3 Hz, 2H), 1.15 (t, J = 7.3 Hz, 3H) o
( 2 ) 制备化学式 (Id)所示化合物 (2) Preparation of a compound of formula (Id)
化学式 (Illd)所示化合物 (23.1 g)溶解于二氯甲垸 (280 mL)中, 冷却至 The compound of formula (Illd) (23.1 g) was dissolved in dichloromethane (280 mL) and cooled to
-40 °C, 缓慢加入四氯化钛 (13.2 g) ,所得的黄色浆状物继续搅拌 30分钟。 缓慢加入三乙胺 (14.1 g) , 然后反应液升至 -20°C并继续搅拌 1小时, 然后 缓慢加入 4AA (20 g)的二氯甲垸 (40 mL)溶液。 在 -20°C下搅拌 3小时后,
将反应物升温至室温, 然后用水 (150 mL)淬灭。 静置分层, 分出二氯甲垸 相, 然后浓縮得化学式 (XVId)所示化合物的粗品 44.2 Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes. Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 ° C for 3 hours, The reaction was warmed to rt then EtOAc (EtOAc)EtOAc. The mixture was allowed to stand for separation, the methylene chloride phase was separated, and then concentrated to give a crude product of the formula (XVId).
将化学式 (XVId)所示化合物的粗品 (44.2 g ) 悬浮于 50%的乙腈溶液 The crude product (44.2 g) of the compound of formula (XVId) was suspended in 50% acetonitrile solution.
(120 mL)中, 在 15~20。C下加入 3N HC1 (40 mL)。 反应在 15-20。C下搅 拌直至反应完全。加入 120 mL乙酸乙酯,用饱和碳酸氢钠调节水相的 pH 到 6~7。 静置分出有机相, 用 45 mL饱和食盐水洗涤, 浓縮, 硅胶柱色谱 纯化得到化学式 (Id)所示化合物(12.2 g, 两步 45%产率), β/α 比为 8.5: 1。 (120 mL), in 15~20. Add 3N HC1 (40 mL) to C. The reaction is at 15-20. Stir under C until the reaction is complete. 120 mL of ethyl acetate was added and the pH of the aqueous phase was adjusted to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 45 mL of brine, concentrated, and purified by silica gel column chromatography to give the compound of formula (Id) (12.2 g, two-step 45% yield) with a ratio of 8.5:1. .
!H NMR ( β异构体) (400 MHz, CDC13): δ 8.09 (dd, J = 8.6, 1.2 Hz, ! H NMR (β-isomer) (400 MHz, CDC1 3) : δ 8.09 (dd, J = 8.6, 1.2 Hz,
1H), 7.68 (td, J = 7.4 , 1.2 Hz), 7.53 (t, J = 7.4 Hz, 2H), 6.51 (s, 1H), 5.64 (s, 2H), 4.06-4.11 (m, 1H), 3.82 (dd, J = 6.3, 2.1 Hz, 1H), 3.70-3.76 (m, 1H),1H), 7.68 (td, J = 7.4, 1.2 Hz), 7.53 (t, J = 7.4 Hz, 2H), 6.51 (s, 1H), 5.64 (s, 2H), 4.06-4.11 (m, 1H), 3.82 (dd, J = 6.3, 2.1 Hz, 1H), 3.70-3.76 (m, 1H),
2.88 (dd, J = 6.8, 2.0 Hz, 1H), 2.67 (brs, 1H), 1.25 (d, J = 6.4 Hz, 3H), 1.182.88 (dd, J = 6.8, 2.0 Hz, 1H), 2.67 (brs, 1H), 1.25 (d, J = 6.4 Hz, 3H), 1.18
(d, J = 6.5 Hz, 3H (d, J = 6.5 Hz, 3H
实施例 Example
( 1 ) 制备化学式 (Hie)所示化合物 (1) Preparation of a compound of the formula (Hie)
在约 20 °C下加入 2, 4-二氯苄醇(124 g)、 3-氧代戊酸甲酯(100 g)和 甲苯 (300 mL), 加热至回流, 采用常压蒸馏装置蒸出溶剂至体系温度升至 150 °C。 重复 3~4次, 所得化学式 (XVIIe)所示化合物的粗品直接用于下 一步反应。 Add 2,4-dichlorobenzyl alcohol (124 g), methyl 3-oxopentanoate (100 g) and toluene (300 mL) at about 20 ° C, heat to reflux, and distill off with an atmospheric distillation apparatus. Solvent to system temperature rose to 150 °C. The crude product of the obtained compound of the formula (XVIIe) was directly used in the next reaction 3 to 4 times.
在约 20°C 下加入上述化学式 (XVIIe)所示化合物的粗品, 甲苯 (300 mL)和三乙胺 (35.4 g), 然后滴加对十二垸基苯磺酰叠氮 (270.4 g)。 滴毕, 自然恢复到室温反应 5小时。 反应体系浓縮至约 200~300 mL, 然后加入 正庚垸 (500 mL), 冰水浴冷却搅拌约 2小时。 过滤, 滤饼用正庚垸洗涤, 干燥得到化学式 (Hie)所示化合物(158 g, 产率 75%) , 液相纯度 98.9%。 The crude compound of the above formula (XVIIe), toluene (300 mL) and triethylamine (35.4 g) were added at about 20 ° C, then p-dodecylbenzenesulfonyl azide (270.4 g) was added dropwise. After the completion of the dropwise addition, the reaction was naturally returned to room temperature for 5 hours. The reaction system was concentrated to about 200 to 300 mL, then n-glycol (500 mL) was added, and the mixture was cooled and cooled in an ice water bath for about 2 hours. After filtration, the filter cake was washed with n-glycol and dried to give a compound of the formula (Hie) (158 g, yield: 75%), and the liquid phase purity was 98.9%.
!H NMR (400 MHz, CDC13): δ 7.42 (s, 1H), 7.32-7.42 (m, 1H), 7.25-7.27 (m, 1H), 5.31 (s, 2H), 2.85 (q, J = 7.3 Hz, 2H), 1.13 (t, J = 7.3 Hz,
3H ! H NMR (400 MHz, CDC1 3): δ 7.42 (s, 1H), 7.32-7.42 (m, 1H), 7.25-7.27 (m, 1H), 5.31 (s, 2H), 2.85 (q, J = 7.3 Hz, 2H), 1.13 (t, J = 7.3 Hz, 3H
(2 ) 制备化学式 (Ie)所示化合物 (2) Preparation of a compound of the formula (Ie)
化学式 (Ille)所示化合物 (25.1 g)溶解于二氯甲垸 (280 mL)中, 冷却至 The compound of formula (Ille) (25.1 g) was dissolved in dichloromethane (280 mL) and cooled to
-40°C, 缓慢加入四氯化钛 (13.2 g), 所得的黄色浆状物继续搅拌 30分钟。 缓慢加入三乙胺 (14.1 g), 然后反应液升至 -20°C并继续搅拌 1小时, 然后 缓慢加入 4AA (20 g)的二氯甲垸 (40 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至室温, 然后用水 (150 mL)淬灭。 静置分层, 分出二氯甲垸 相, 然后浓縮得化学式 (XVIe)所示化合物的粗品 47.4 g。 Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes. Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to EtOAc EtOAc. The mixture was allowed to stand for separation, and the methylene chloride phase was separated, and then concentrated to give 47.4 g of crude compound of formula (XVI).
将化学式 (XVIe)所示化合物的粗品 (47.4 g ) 悬浮于 40%的乙腈水溶 液(120 mL)中, 在 15~20°C下加入 3N HC1 (40 mL)。 反应在 15~20 °C下 搅拌直至反应完全。 加入 120 mL乙酸乙酯, 用饱和碳酸氢钠调节水相的 pH到 6~7。 静置分出有机相, 用 45 mL饱和食盐水洗涤, 浓縮, 硅胶柱 色谱纯化得到化学式 (Ie)所示化合物(14.1 g, 两步 49%产率), β/α 比为 10 The crude compound (47.4 g) of the compound of the formula (XVIe) was suspended in 40% aqueous acetonitrile (120 mL), and 3N HCl (40 mL) was added at 15 to 20 °C. The reaction was stirred at 15 to 20 ° C until the reaction was completed. 120 mL of ethyl acetate was added and the pH of the aqueous phase was adjusted to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 45 mL of brine, concentrated, and purified by silica gel chromatography to give the compound of formula (Ie) (14.1 g, two-step 49% yield) with a ratio of β/α of 10
!H NMR ( β异构体) (400 MHz, CDC13): δ 7.38 (ά, J = 2.0 Hz, 1H), 7.30 (d, J = 8.2 Hz, 1H), 7.23 (dd, J = 8.2, 2.0 Hz, 1H), 6.74 (s, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J = 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H), 3.36 (brs, 1H), 2.85 (dd, J = 6.6, 1.8 Hz, 1H), 1.22 (d, J = 6.9 Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H ! H NMR (β-isomer) (400 MHz, CDC1 3) : δ 7.38 (ά, J = 2.0 Hz, 1H), 7.30 (d, J = 8.2 Hz, 1H), 7.23 (dd, J = 8.2, 2.0 Hz, 1H), 6.74 (s, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J = 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H ), 3.36 (brs, 1H), 2.85 (dd, J = 6.6, 1.8 Hz, 1H), 1.22 (d, J = 6.9 Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H
以上特别说明和描述了具体实施方式。 对于本领域普通技术人员而 言, 所述公开不限于实施方式, 在所附权利要求书的精神和范围内, 所有 适当的修饰或等同替换都将落入所述公开的范围之内。
The specific embodiments have been particularly described and described above. It is intended that the present invention is not to be construed as being limited by the scope of the disclosure.
Claims
1. 一种制备培南类抗生素中间体的方法, 其特征在于, 包括以下步 骤: 1. A method for preparing penem antibiotic intermediates, characterized in that it includes the following steps:
步骤 1 : 由化学式 σι)所示化合物与化学式 σιι)所示化合物反应得到 化学式 (XVI)所示化合物; Step 1: The compound represented by chemical formula (XVI) is obtained by reacting the compound represented by chemical formula σί) and the compound represented by chemical formula σί);
步骤 2 : 由所述化学式 (XVI)所示化合物制备化学式 所示的培南类 抗生素中间体; Step 2: Prepare the penem antibiotic intermediate represented by the chemical formula from the compound represented by the chemical formula (XVI);
所述方法合成路线如下: The synthetic route of the method is as follows:
II III XVI 其中, R1代表甲基、 乙基、 对硝基苄基、 苄基、 烯丙基、 4-氯苄基、 2-硝基苄基、 3-硝基苄基或 4-甲氧基苄基; R2代表乙酰基或苯甲酰基; II III Oxybenzyl; R 2 represents acetyl or benzoyl;
R3代表三甲基硅基或叔丁基二甲基硅基。 R 3 represents trimethylsilyl or tert-butyldimethylsilyl.
2. 根据权利要求 1的方法, 其特征在于, 所述步骤 1的反应在路易 斯酸催化的直接曼尼奇反应条件下进行。 2. The method according to claim 1, characterized in that the reaction of step 1 is carried out under direct Mannich reaction conditions catalyzed by Lewis acid.
3. 根据权利要求 2的方法, 其特征在于, 所述用于曼尼奇反应的路 易斯酸选自四氯化钛、 四溴化钛、 四氯化硅、 三氯化镧、 氯化锌、 溴化 锌、 氯化镁、 三溴化硼、 氯化铜、 三氟甲磺酸铜、 三氟甲磺酸亚铜、 碘 化亚铜或三氯化硼, 优选四氯化钛。 3. The method according to claim 2, characterized in that the Lewis acid used for Mannich reaction is selected from titanium tetrachloride, titanium tetrabromide, silicon tetrachloride, lanthanum trichloride, zinc chloride, Zinc bromide, magnesium chloride, boron tribromide, copper chloride, copper triflate, copper triflate, copper iodide or boron trichloride, preferably titanium tetrachloride.
4. 根据权利要求 3的方法, 其特征在于, 所述路易斯酸与所述化学 式 (II)所示化合物的摩尔比为 0.8~3.0: 1, 优选 1.0~1.5: 1。 4. The method according to claim 3, characterized in that the molar ratio of the Lewis acid to the compound represented by the chemical formula (II) is 0.8~3.0:1, preferably 1.0~1.5:1.
5. 根据权利要求 2的方法, 其特征在于, 所述步骤 1的反应中还存 在路易斯碱, 其选自三乙胺、 二异丙基乙胺、 三丁胺、 四甲基乙二胺、 4-甲基吗啉、 1,8-二氮杂双环 [5.4.0] ^—碳 -7-烯、 1,4-二氮杂二环 [2.2.2] 辛垸、 4-二甲胺基吡啶、 N-甲基吡咯垸、 N-甲基哌啶、 二乙胺、 二异丙
胺、 吡咯、 哌啶、 六甲基磷酰三胺、 吡啶、 3-甲基吡啶或它们的组合, 优选其中的三级胺。 5. The method according to claim 2, characterized in that a Lewis base also exists in the reaction of step 1, which is selected from the group consisting of triethylamine, diisopropylethylamine, tributylamine, tetramethylethylenediamine, 4-methylmorpholine, 1,8-diazabicyclo[5.4.0]-carbon-7-ene, 1,4-diazabicyclo[2.2.2]octane, 4-dimethylamine Pyridine, N-methylpyrrole, N-methylpiperidine, diethylamine, diisopropyl Amine, pyrrole, piperidine, hexamethylphosphoric triamide, pyridine, 3-methylpyridine or combinations thereof, with tertiary amines among them being preferred.
6. 根据权利要求 5的方法, 其特征在于, 所述路易斯碱与所述化学 式 (II)所示化合物的摩尔比为 1.2~4.0: 1, 优选 1.8~2.5: 1。 6. The method according to claim 5, characterized in that the molar ratio of the Lewis base and the compound represented by the chemical formula (II) is 1.2~4.0:1, preferably 1.8~2.5:1.
7. 根据权利要求 2的方法, 其特征在于, 所述步骤 1的反应在溶剂 中进行, 所述溶剂选自二氯甲垸、 1,2-二氯乙垸、 甲苯、 乙腈、 四氢呋喃、 甲基叔丁基醚、 2-甲基四氢呋喃或它们的组合, 优选二氯甲垸、 1,2-二氯 乙垸或它们的组合; 所述溶剂的用量为每克所述化学式 (Π)所示化合物使 用 8~30 mL, 优选为每克所述化学式 (II)所示化合物使用 12~20 mL。 7. The method according to claim 2, characterized in that the reaction of step 1 is carried out in a solvent, and the solvent is selected from the group consisting of dichloromethane, 1,2-dichloroethane, toluene, acetonitrile, tetrahydrofuran, and methane. tert-butyl ether, 2-methyltetrahydrofuran or a combination thereof, preferably dichloromethane, 1,2-dichloroethane or a combination thereof; the amount of the solvent is 1 gram of the chemical formula (II) 8 to 30 mL of the compound represented by the chemical formula (II) is used, preferably 12 to 20 mL per gram of the compound represented by the chemical formula (II).
8. 根据权利要求 2的方法, 其特征在于, 所述化学式 (ΙΠ)所示化合 物与所述化学式 (Π)所示化合物的摩尔比为 1.0~2.0 : 1, 优选 1.2~1.5: 1。 8. The method according to claim 2, characterized in that the molar ratio of the compound represented by the chemical formula (ΙΠ) and the compound represented by the chemical formula (Π) is 1.0~2.0:1, preferably 1.2~1.5:1.
9. 根据权利要求 2的方法, 其特征在于, 所述步骤 1的反应温度为 -60~10。C, 优选 -30~0 °C。 9. The method according to claim 2, characterized in that the reaction temperature of step 1 is -60~10. C, preferably -30~0°C.
10. 根据权利要求 2的方法, 其特征在于, 所述步骤 1反应完成后, 采用以下淬灭溶液淬灭反应: 氯化钠溶液、 碳酸氢钠溶液、 磷酸二氢钠 溶液、 磷酸二氢钾溶液、 氯化镁溶液、 氯化钙溶液或纯水, 优选纯水; 所述淬灭溶液的用量为每克所述化学式 (II)所示化合物使用 3~30 mL, 优 选为每克所述化学式 (Π)所示化合物使用 5~10 mL。 10. The method according to claim 2, characterized in that, after the reaction in step 1 is completed, the following quenching solution is used to quench the reaction: sodium chloride solution, sodium bicarbonate solution, sodium dihydrogen phosphate solution, potassium dihydrogen phosphate solution, magnesium chloride solution, calcium chloride solution or pure water, preferably pure water; the dosage of the quenching solution is 3 to 30 mL per gram of the compound represented by the chemical formula (II), preferably 3 to 30 mL per gram of the chemical formula (II) Use 5~10 mL of the compound shown in Π).
11. 根据权利要求 1的方法, 其特征在于, 所述步骤 2的反应在采用 酸催化脱除三甲基硅基或叔丁基二甲基硅基的反应条件下进行。 11. The method according to claim 1, characterized in that the reaction in step 2 is carried out under the reaction conditions of acid-catalyzed removal of trimethylsilyl or tert-butyldimethylsilyl.
12. 根据权利要求 11的方法, 其特征在于, 所述酸选自盐酸、 硫酸、 甲基磺酸、 苯磺酸或三氟乙酸, 优选盐酸。 12. The method according to claim 11, characterized in that the acid is selected from hydrochloric acid, sulfuric acid, methylsulfonic acid, benzenesulfonic acid or trifluoroacetic acid, preferably hydrochloric acid.
13. 根据权利要求 12 的方法, 其特征在于, 所述酸的浓度为 0.5~4 mol/L, 优选为 1.0~2.0 mol/L。 13. The method according to claim 12, characterized in that the concentration of the acid is 0.5~4 mol/L, preferably 1.0~2.0 mol/L.
14. 根据权利要求 11的方法, 其特征在于, 所述步骤 2的反应在溶
剂中进行, 所述溶剂选自乙腈 -水、 甲醇 -水、 丙酮-水或四氢呋喃 -水, 优 选乙腈 -水。 14. The method according to claim 11, characterized in that the reaction of step 2 is carried out in a solvent It is carried out in a solvent selected from acetonitrile-water, methanol-water, acetone-water or tetrahydrofuran-water, preferably acetonitrile-water.
15. 根据权利要求 11的方法, 其特征在于, 所述步骤 2的反应温度 为 0~30°C, 优选 15~20°C。
15. The method according to claim 11, characterized in that the reaction temperature of step 2 is 0~30°C, preferably 15~20°C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2013/087038 WO2015070394A1 (en) | 2013-11-13 | 2013-11-13 | Method for preparing penem antibiotic intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2013/087038 WO2015070394A1 (en) | 2013-11-13 | 2013-11-13 | Method for preparing penem antibiotic intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015070394A1 true WO2015070394A1 (en) | 2015-05-21 |
Family
ID=53056616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/087038 WO2015070394A1 (en) | 2013-11-13 | 2013-11-13 | Method for preparing penem antibiotic intermediate |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015070394A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105315299A (en) * | 2015-09-22 | 2016-02-10 | 盐城开元医药化工有限公司 | Synthesis method of ceftizoxime mother nucleus 7-ANCA |
CN105906529A (en) * | 2016-06-07 | 2016-08-31 | 江西富祥药业股份有限公司 | 4-halogenated-2-diazo-3-oxo-valeric acid(4-nitrobenzene)methyl ester and preparation method thereof |
CN117186116A (en) * | 2023-09-07 | 2023-12-08 | 浙江荣耀生物科技股份有限公司 | Preparation method of cefvicin intermediate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4841043A (en) * | 1985-12-23 | 1989-06-20 | Bristol-Myers Company | Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates |
CN1610663A (en) * | 2002-03-25 | 2005-04-27 | 高砂香料工业株式会社 | The preparation method of azetidinone compound |
CN102936217A (en) * | 2012-11-08 | 2013-02-20 | 浙江新东港药业股份有限公司 | Preparation method of intermediate for penem |
-
2013
- 2013-11-13 WO PCT/CN2013/087038 patent/WO2015070394A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4841043A (en) * | 1985-12-23 | 1989-06-20 | Bristol-Myers Company | Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates |
CN1610663A (en) * | 2002-03-25 | 2005-04-27 | 高砂香料工业株式会社 | The preparation method of azetidinone compound |
CN102936217A (en) * | 2012-11-08 | 2013-02-20 | 浙江新东港药业股份有限公司 | Preparation method of intermediate for penem |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105315299A (en) * | 2015-09-22 | 2016-02-10 | 盐城开元医药化工有限公司 | Synthesis method of ceftizoxime mother nucleus 7-ANCA |
CN105315299B (en) * | 2015-09-22 | 2017-06-27 | 盐城开元医药化工有限公司 | A kind of synthetic method of the ANCA of Ceftizoxime parent nucleus 7 |
CN105906529A (en) * | 2016-06-07 | 2016-08-31 | 江西富祥药业股份有限公司 | 4-halogenated-2-diazo-3-oxo-valeric acid(4-nitrobenzene)methyl ester and preparation method thereof |
CN105906529B (en) * | 2016-06-07 | 2018-11-27 | 江西富祥药业股份有限公司 | Halogenated -2- diazonium -3- the oxo-pentanoic acid of 4- (4- nitrobenzene) methyl esters and preparation method thereof |
CN117186116A (en) * | 2023-09-07 | 2023-12-08 | 浙江荣耀生物科技股份有限公司 | Preparation method of cefvicin intermediate |
CN117186116B (en) * | 2023-09-07 | 2024-06-07 | 浙江荣耀生物科技股份有限公司 | Preparation method of cefvicin intermediate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5784602B2 (en) | Process for the production of pharmaceutically active compounds | |
TW202016077A (en) | Novel processes | |
CN102424686A (en) | Process for the preparation of high-purity prasugrel hydrochloride | |
WO2015070394A1 (en) | Method for preparing penem antibiotic intermediate | |
CN101967118B (en) | Preparation method of alvimopan | |
WO2017163257A1 (en) | Process for preparing pure lh-pyrazolo[3,4-d] pyrimidine derivative | |
CN115819319A (en) | A kind of amide compound, its preparation method and its application | |
CA2537536A1 (en) | Process for the preparation of renzapride and intermediates thereof | |
EP3911660B1 (en) | Process for preparation of 2-amino-5-hydroxy propiophenone | |
CN103553995A (en) | Method for preparing penem antibiotic midbody | |
US6921839B2 (en) | Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem | |
JPWO2008020597A1 (en) | Method for producing 1-methylcarbapenem intermediate | |
JPH10502620A (en) | Preparation of alkylating agents and their use for alkylating cyclic ureas | |
CN112321398B (en) | Method for synthesizing alpha-fluorinated ketone by hydrazonating aliphatic chain monoketone | |
JP3184345B2 (en) | Method for producing 5-chlorooxindole | |
CN1414959A (en) | Process for production of 5-oxy-7-oxabicyclo-[4.1.0]hept-3-ENE-3-carboxylic acid esters | |
JPH01311060A (en) | 3, 4-dihydroxy-2-pyroliginone derivative | |
JP3238512B2 (en) | Method for producing sulfamides | |
Eagles et al. | Synthesis of d-camphor based γ-amino acid (1S, 3R)-3-amino-2, 2, 3-trimethylcyclopentane carboxylic acid | |
TW202513046A (en) | Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide | |
Meiries et al. | Synthesis of the trichloroacetamide derivative of enantio-iso-ADDA methyl ester | |
WO2014147464A2 (en) | Novel process for the preparation of tolcapone | |
JPH05221947A (en) | Production of cyclopropane derivative | |
JP3418725B2 (en) | Simple method for producing 1,1-bis (4-aminophenyl) ethane | |
JPH0812658A (en) | Production of sydnones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13897558 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13897558 Country of ref document: EP Kind code of ref document: A1 |